 Igor Kogut
Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Induced Pluripotent Stem Cells | 9 | 2027 | 272 | 1.870 |
Why?
| | Gene Editing | 2 | 2024 | 91 | 0.830 |
Why?
| | CRISPR-Cas Systems | 2 | 2024 | 167 | 0.800 |
Why?
| | Cellular Reprogramming Techniques | 2 | 2020 | 10 | 0.700 |
Why?
| | Fibroblasts | 5 | 2027 | 1023 | 0.560 |
Why?
| | Keratinocytes | 2 | 2020 | 250 | 0.500 |
Why?
| | Cell Differentiation | 7 | 2025 | 2045 | 0.450 |
Why?
| | Cell Culture Techniques | 3 | 2020 | 373 | 0.400 |
Why?
| | Chromosomes, Fungal | 1 | 2009 | 42 | 0.300 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2009 | 130 | 0.280 |
Why?
| | B-Lymphocytes | 1 | 2012 | 878 | 0.240 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2009 | 419 | 0.230 |
Why?
| | Cell Cycle Proteins | 1 | 2009 | 631 | 0.220 |
Why?
| | Saccharomyces cerevisiae | 1 | 2009 | 580 | 0.220 |
Why?
| | Amniotic Fluid | 1 | 2025 | 79 | 0.220 |
Why?
| | Cell Line | 2 | 2022 | 2823 | 0.210 |
Why?
| | Cellular Senescence | 1 | 2027 | 225 | 0.210 |
Why?
| | Primary Cell Culture | 2 | 2020 | 172 | 0.180 |
Why?
| | Genetic Engineering | 2 | 2020 | 89 | 0.180 |
Why?
| | RNA | 2 | 2020 | 929 | 0.180 |
Why?
| | Regenerative Medicine | 1 | 2022 | 48 | 0.170 |
Why?
| | Collagen Type VII | 1 | 2021 | 27 | 0.170 |
Why?
| | Jews | 1 | 2021 | 20 | 0.170 |
Why?
| | Sequence Analysis, DNA | 1 | 2024 | 831 | 0.170 |
Why?
| | Skin | 1 | 2027 | 766 | 0.170 |
Why?
| | Cellular Reprogramming | 2 | 2020 | 99 | 0.170 |
Why?
| | Aging | 1 | 2012 | 1940 | 0.170 |
Why?
| | Epidermolysis Bullosa Dystrophica | 1 | 2021 | 41 | 0.170 |
Why?
| | Cells, Cultured | 6 | 2027 | 4127 | 0.160 |
Why?
| | Skin Transplantation | 1 | 2020 | 85 | 0.150 |
Why?
| | Genes, Reporter | 1 | 2020 | 276 | 0.140 |
Why?
| | Munc18 Proteins | 1 | 2018 | 24 | 0.140 |
Why?
| | Green Fluorescent Proteins | 1 | 2020 | 407 | 0.140 |
Why?
| | Exocytosis | 1 | 2018 | 85 | 0.140 |
Why?
| | DNA | 1 | 2024 | 1451 | 0.130 |
Why?
| | Endothelial Cells | 1 | 2022 | 866 | 0.110 |
Why?
| | Humans | 14 | 2027 | 145491 | 0.110 |
Why?
| | Gene Expression | 1 | 2020 | 1478 | 0.110 |
Why?
| | Synapses | 1 | 2018 | 438 | 0.110 |
Why?
| | Collagen Type IV | 1 | 2014 | 27 | 0.100 |
Why?
| | Bone Morphogenetic Protein 4 | 1 | 2014 | 44 | 0.100 |
Why?
| | Collagen Type I | 1 | 2014 | 143 | 0.100 |
Why?
| | Tretinoin | 1 | 2014 | 125 | 0.090 |
Why?
| | Peptides | 1 | 2018 | 993 | 0.090 |
Why?
| | Clonal Anergy | 1 | 2012 | 54 | 0.090 |
Why?
| | Cell Adhesion | 1 | 2014 | 452 | 0.090 |
Why?
| | Lymphopoiesis | 1 | 2012 | 27 | 0.090 |
Why?
| | MicroRNAs | 1 | 2018 | 689 | 0.090 |
Why?
| | Gammaherpesvirinae | 1 | 2012 | 45 | 0.090 |
Why?
| | B-Lymphocyte Subsets | 1 | 2012 | 79 | 0.090 |
Why?
| | Herpesviridae Infections | 1 | 2012 | 149 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2018 | 2820 | 0.080 |
Why?
| | Immune Tolerance | 1 | 2012 | 384 | 0.080 |
Why?
| | Antibodies, Neutralizing | 1 | 2012 | 342 | 0.070 |
Why?
| | Kinetochores | 1 | 2009 | 55 | 0.070 |
Why?
| | Antibodies, Viral | 1 | 2012 | 673 | 0.070 |
Why?
| | Homeostasis | 1 | 2012 | 639 | 0.070 |
Why?
| | Cell Cycle | 1 | 2009 | 595 | 0.060 |
Why?
| | Immunoassay | 1 | 2027 | 108 | 0.060 |
Why?
| | Amniocentesis | 1 | 2025 | 20 | 0.060 |
Why?
| | Chromatin | 1 | 2009 | 555 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2012 | 2499 | 0.050 |
Why?
| | Vaccination | 1 | 2012 | 1423 | 0.050 |
Why?
| | Embryoid Bodies | 1 | 2022 | 8 | 0.040 |
Why?
| | Thy-1 Antigens | 1 | 2022 | 11 | 0.040 |
Why?
| | Chile | 1 | 2021 | 27 | 0.040 |
Why?
| | Colombia | 1 | 2021 | 43 | 0.040 |
Why?
| | Genes, Recessive | 1 | 2021 | 78 | 0.040 |
Why?
| | Mexico | 1 | 2021 | 234 | 0.040 |
Why?
| | Myocytes, Cardiac | 1 | 2025 | 544 | 0.040 |
Why?
| | Gene Knock-In Techniques | 1 | 2020 | 61 | 0.040 |
Why?
| | Gene Targeting | 1 | 2020 | 80 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2020 | 82 | 0.040 |
Why?
| | Syntaxin 1 | 1 | 2018 | 14 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 335 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2020 | 202 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2018 | 220 | 0.030 |
Why?
| | Models, Animal | 1 | 2020 | 395 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2020 | 613 | 0.030 |
Why?
| | Animals | 3 | 2020 | 38141 | 0.030 |
Why?
| | Protein Transport | 1 | 2018 | 438 | 0.030 |
Why?
| | Transfection | 1 | 2018 | 925 | 0.030 |
Why?
| | Synaptic Transmission | 1 | 2018 | 292 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2025 | 6437 | 0.020 |
Why?
| | Phenotype | 1 | 2021 | 3157 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 84 | 0.020 |
Why?
| | Protein Binding | 1 | 2018 | 2250 | 0.020 |
Why?
| | Pregnancy | 1 | 2025 | 7197 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2012 | 320 | 0.020 |
Why?
| | Liver | 1 | 2020 | 1895 | 0.020 |
Why?
| | Acute Disease | 1 | 2012 | 1040 | 0.020 |
Why?
| | Neurons | 1 | 2018 | 1647 | 0.020 |
Why?
| | Mice | 2 | 2020 | 18338 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1134 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2189 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2012 | 3125 | 0.010 |
Why?
| | Female | 2 | 2025 | 78763 | 0.010 |
Why?
| | Signal Transduction | 1 | 2018 | 5202 | 0.010 |
Why?
| | United States | 1 | 2021 | 16115 | 0.010 |
Why?
| | Adult | 1 | 2025 | 40707 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2012 | 5989 | 0.010 |
Why?
| | Male | 1 | 2021 | 72817 | 0.010 |
Why?
|
|
Kogut's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|